Canada Markets open in 8 hrs 27 mins

Novartis AG (NVS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
84.84+1.48 (+1.78%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close83.36
Bid0.00 x 900
Ask0.00 x 2200
Day's Range83.77 - 85.32
52 Week Range77.04 - 98.52
Avg. Volume1,969,189
Market Cap190.994B
Beta (5Y Monthly)0.52
PE Ratio (TTM)24.38
EPS (TTM)3.48
Earnings DateN/A
Forward Dividend & Yield3.20 (3.47%)
Ex-Dividend DateMar. 04, 2021
1y Target Est103.33
  • Motley Fool

    Novartis (NVS) Q3 2021 Earnings Call Transcript

    NVS earnings call for the period ending September 30, 2021.

  • Zacks

    Novartis (NVS) Q3 Earnings Beat, Sandoz Under Strategic Review

    Novartis (NVS) reports mixed results in the third quarter, as key brands maintain momentum but generics business remains weak.

  • Bloomberg

    Novartis Starts Review of Generic-Drug Unit

    Novartis AG may spin off or sell its Sandoz generic-drug unit after it consistently failed to meet expectations, with U.S. sales plummeting this year amid the Covid-19 pandemic. Chief Executive Officer Vas Narasimhan says now is the right moment to reconsider its strategic fit, and the company will explore all options. He also discusses third-quarter growth and Covid treatments with Bloomberg's Dani Burger on "Bloomberg Markets: Europe."